Estrogen supplementation for bone dematuration in young epileptic man treated with anticonvulsant therapy; A case report

Endocrine Journal

Volumn 46, Issue 2, 1999, Pages 301-307

  Yamano, Yuriko ^a   Sakane, Sadaki ^a   Takamatsu, Junta ^a   Ohsawa, Nakaaki ^a  

^a OSAKA MEDICAL COLLEGE   (Japan)

Author keywords

Anticonvulsant; Aromatase; Bone maturation; Estrogen

Indexed keywords

ANTICONVULSIVE AGENT; AROMATASE; CARBAMAZEPINE; CONJUGATED ESTROGEN; ESTRADIOL; LEVOTHYROXINE; PHENOBARBITAL; PHENYTOIN; PREMALINE; TESTOSTERONE; UNCLASSIFIED DRUG; VALPROIC ACID; ZONISAMIDE;

ADULT; ANTICONVULSANT THERAPY; ARTICLE; BONE DEMINERALIZATION; BONE DENSITY; BONE MATURATION; BONE MINERAL; CASE REPORT; CLINICAL FEATURE; DISEASE COURSE; DRUG EFFICACY; ENZYME ASSAY; EPILEPSY; ESTRADIOL BLOOD LEVEL; ESTROGEN THERAPY; HUMAN; MALE; RADIODIAGNOSIS; TESTOSTERONE BLOOD LEVEL; TREATMENT OUTCOME;

EID: 0032997194     PISSN: 09188959     EISSN: None     Source Type: Journal    
DOI: 10.1507/endocrj.46.301     Document Type: Article

References (14)

1. Richens A, Rowe DJF (1970) Disturbance of calcium metabolism by anticonvulsant drugs. Br Med J 4: 73-76.
2. Dent CE, Richens A, Rowe DJF, Stamp TCB (1970) Osteomalacia with long-term anticonvulsant therapy in epilepsy. Br Med J 4: 69-72.
3. Smith EP, Boyd J, Frank GR, Takahashi H, Cohen RM (1994) Estrogen resistance caused by a mutation in the estrogen receptor gene in a man. N Engl J Med 331: 1056-1061.
4. Morishima A, Grumbach MM, Simpson ER, Fisher C, Qin K (1995) Aromatase deficiency in male and female siblings caused by a novel mutation and the physiological role of estrogens. J Clin Endocrinol Metab 80: 3689-3698.
5. Mullis PE, Yoshimura N, Kuhlmann B, Lippuner K, Jaeger P, Harada H (1997) Aromatase deficiency in a female who is compound heterozygote for two point mutations in the P450 arom gene: impact of estrogens on hypergonadotropic hypogonadism, multicystic ovaries, and bone densitometry in childhood. J Clin Endocrinol Metab 82: 1739-1745.
6. Frank GR (1995) The role of estrogen in pubertal skeletal physiology: epiphyseal maturation and mineralization of the skeleton. Acta Paediatr 84: 627-630.
7. Mazess RB, Collick B, Trempe J, Barden H, Hanson J (1989) Performance evaluation of a dual-energy x-ray bone densitometer. Calcif Tissue Int 44: 228-232.
8. Murakami Y, Takamatsu J, Sakane S, Kuma K, Ohsawa N (1996) Changes in thyroid volume in response to radioactive iodine for Graves' hyperthyroidism correlated with activity of thyroid-stimulating antibody and treatment outcome. J Clin Endocrinol Metab 81: 3257-3260.
9. Means GD, Mahendroo MS, Corbin CJ, Mathis JM, Powell FE, Mendelson CR, Simpson ER (1989) Structural analysis of the gene encoding human aromatase cytochrome P-450, the enzyme responsible for estrogen biosynthesis. J Biol Chem 264: 19385-19391.
10. Conte FA, Grumbach MM, Ito Y, Fisher CR, Simpson ER (1994) A syndrome of female pseudohermaphrodism, hypergonadotropic hypogonadism, and multicystic ovaries associated with missense mutations in the gene encoding aromatase (P450 arom). J Clin Endocrinol Metab 78: 1287-1292.
11. Ohnishi T, Ichikawa Y (1997) Direct inhibitions of the activities of steroidogenic cytochrome P-450 monooxygenase systems by anticonvulsants. J Steroid Biochem. Molec Biol 60: 77-85.
12. Vanderschueren D, Herck EV, Nijs J, Ederveen AGH, Coster RD, Bouillon R (1997) Aromatase inhibition impairs skeletal modeling and decreases bone mineral density in growing male rats. Endocrinology 138: 2301-2307.
13. Finkelstein JS, Klibanski A, Neer RM, Doppelt SH, Rosenthal DI, Segre GV, Crowley Jr WF (1989) Increases in bone density during treatment of men with hypogonadotropic hypogonadism. J Clin Endocrinol Metab 69: 776-783.
14. Finkelstein JS, Neer RM, Biller BMK, Crawford JD, Klibanski A (1992) Osteopenia in men with a history of delayed puberty. N Engl J Med 326: 600-604.